in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Teva to restructure operations, cut 5,000 jobs worldwide
October 11, 2013 | Natasha Alperowicz
Teva Pharmaceutical Industries (Petach Tikva, Israel), the world’s leading generic drugs maker, has announced plans to restructure its business, including a reduction of some 5,000 jobs, approximately 10% of its global workforce. The company says that these steps are part of its worldwide restructuring program, which includes divestment of noncore assets, improvement in manufacturing efficiency and reduction of excess capacity. The company expects to realize annualized cost savings of $2 billion by end 2017, compared with the previously guided $1.5 to $2.0...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee